Published in Mental Health Law Weekly, August 21st, 2004
"Pediatric patients with brain tumors can loose 1 SD of height prior to beginning growth hormone (GH) therapy. The objectives of this study were to characterize the early growth failure, identify contributing factors and propose interventions.
"Five children were followed quarterly for 2 years to monitor auxological parameters, nutritional indices, and endocrine measurements," stated the researchers.
"GH stimulation tests were done every 6 months to determine the timing of the onset of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.